
Zika Virus Biology, Transmission, and Pathways
Volume 1: The Neuroscience of Zika Virus
- 1st Edition - June 25, 2021
- Imprint: Academic Press
- Editors: Colin R. Martin, Caroline Hollins-Martin, Victor R Preedy, Rajkumar Rajendram
- Language: English
- Hardback ISBN:9 7 8 - 0 - 1 2 - 8 2 0 2 6 8 - 5
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 0 3 0 8 - 0
Zika Virus Biology, Transmission, and Pathways: The Neuroscience of Zika, Volume One provides a detailed introduction to the molecular biology of the Zika virus and its features,… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteZika Virus Biology, Transmission, and Pathways: The Neuroscience of Zika, Volume One provides a detailed introduction to the molecular biology of the Zika virus and its features, transmission, and impact on neurological systems. Designed to better readers’ understanding of the Zika virus, this volume features chapters on the immune response, molecular mechanisms, and other areas to better understand underlying pathways. This book has applicability for neuroscientists, neurologists, virologists and anyone working to better understand the evolution and pathogenesis of Zika virus-related conditions.
- Presents the most comprehensive coverage of a broad range of topics related to the neuroscience of Zika, including transmission and virus biology
- Contains an abstract, key facts, a mini dictionary of terms, and summary points to aid in understanding in each chapter
- Features chapters on Zika vectors and fetal imaging
- Includes coverage of microcephaly and developmental delays and examines Zika outbreaks in Brazil, Puerto Rico and India
- Discusses unique topics in Zika biology, associated neuro-inflammation, and impacts on neurological systems
- Cover image
- Title page
- Table of Contents
- Copyright
- Dedication
- Contributors
- Foreword
- Preface
- Section A: Zika virus: Introductory chapters
- Chapter 1: Flaviviruses and where the Zika virus fits in: An overview
- Abstract
- Classification, diversity, and evolution
- Biology of transmission and persistence of MBF and TBF
- Virion structure, genome, and viral protein function
- Viral infection and replication cycle
- Host infection, immune response, and pathogenesis
- Flavivirus emergence and global burden
- Emergence of Aedes-borne flaviviruses
- Emergence of Culex-borne flaviviruses
- Policy and procedures
- Mini-dictionary of terms
- Key facts of flavivirus genera
- Summary points
- Chapter 2: The innate immune response during Zika virus infection
- Abstract
- Introduction
- Importance of pattern recognition receptors (PRRs) in sensing ZIKV
- Type I interferon in ZIKV infection
- Innate immunity against ZIKV in the skin
- Innate immunity against ZIKV in the placenta
- Innate immunity against ZIKV in the brain
- Involvement of autophagy
- Innate immunity evasion by ZIKV
- Policy and procedures
- Mini-dictionary of terms
- Key facts of innate immune response in ZIKV infection
- Summary points
- Chapter 3: The public health perspective of Zika virus infection
- Abstract
- Introduction
- Timeline of the outbreaks
- Epidemiology: Distribution and determinants
- Epidemiological determinants
- Public health consequences
- Prevention and control of Zika virus infections
- Implementation of strategic response framework
- Strengthening of International Health Regulations: Advice to travelers
- Strengthening of the sexual and reproductive health services
- Vector control, surveillance, risk communication, and promotion of research
- Bridging the gap between social and health inequalities
- Conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts of the Zika virus infections
- Summary points
- Chapter 4: Inequality in Zika virus and congenital Zika syndrome
- Abstract
- Inequalities in health
- The macro-drivers of the ZIKV
- Socioeconomic inequality in the prevalence of CZS
- Inequality in the exposure to ZIKV
- Inequality in susceptibility to the effect of ZIKV on CZS
- Sources of differential susceptibility
- Inequality in vector density
- Inequality in the vulnerability to the effect of vector density on ZIKV incidence
- The fundamental determination of ZIKV inequalities
- Socioeconomic implications
- Major knowledge gaps
- Policies to tackle the inequalities
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 5: Lifestyle factors and congenital Zika syndrome: Drugs, alcohol, and beyond
- Abstract
- Introduction
- Socioeconomic condition
- Lifestyle
- Access to information/health education
- Health-care access
- Abortion legislation
- Human rights
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 6: Economic impact of Zika virus infection and associated conditions
- Abstract
- Introduction
- Brief history of ZIKV
- Health economics
- Economic and social impacts of recent outbreaks
- The cost of vector control
- The cost of diagnosis
- The cost of ZIKV-associated microcephaly
- The cost of congenital Zika syndrome
- The costs of ZIKV-associated Guillain-Barré syndrome
- Understand the economic evaluation of health technologies
- Economic evaluation of current and emerging health technologies
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 7: Health promotion, health education, and risk communication for Zika virus disease
- Abstract
- Health promotion and education program during a noncrisis situation
- Risk communication for Zika virus disease
- Mini-dictionary of terms
- Key facts of Zika virus disease or ZVD
- Summary points
- Chapter 8: Molecular mechanisms of Zika virus-induced neurological pathology
- Abstract
- Introduction
- ZIKV impairs mitotic spindle assembly
- Premature neural progenitor cell differentiation during ZIKV infection decreases the number of mature neurons
- ZIKV induces apoptosis in infected and bystander cells
- ZIKV interferes with developmental gene expression programs
- Neuroinflammation
- Conclusions and outstanding questions
- Policy and procedures: Measuring apoptosis
- Mini-dictionary of terms
- Key facts of the unfolded protein response
- Summary points
- Chapter 9: Validation of Zika virus infections: Nonmolecular aspects, immunoassays, and beyond
- Abstract
- Introduction
- Serological methods used in diagnosing ZIKV infection
- Methods for detecting ZIKV antibodies
- Policy and procedures
- Mini-dictionary of terms
- Key facts of immunoassays used for the diagnosis of ZIKV infection
- Summary points
- Chapter 10: Validation of Zika virus infections: A focus on molecular methods
- Abstract
- Introduction
- Real-time RT-PCRs
- Multiplex real-time RT-PCRs
- Conventional RT-PCRs
- Validation criteria
- Policy and procedures
- Mini-dictionary of the terms
- Key facts of molecular tests used for diagnosis of ZIKV infection
- Summary points
- Chapter 11: Coinfection of Zika with Dengue and Chikungunya virus
- Abstract
- Introduction
- Timeline of coinfections
- Distribution of coinfections
- Detection of arboviruses in coinfections
- Clinical outcomes of coinfections
- Conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 12: Zika virus, pathology, and control: Zika vaccine strategies in development
- Abstract
- Introduction
- Adaptive immunity to ZIKV infection
- Key challenges facing Zika vaccine development
- Zika vaccine platforms
- Clinical evaluation of Zika vaccine candidates
- Concluding remarks
- Policy and procedures
- Mini-dictionary of terms
- Key facts on Zika vaccine
- Summary points
- Section B: Effects on neurological and body systems
- Chapter 13: The adult brain and neurologic manifestations of the Zika virus
- Abstract
- Introduction
- Zika virus and the nervous system: NeuroZika
- Guillain-Barré syndrome
- ZIKV-GBS viral diagnosis
- ZIKV-GBS neuroimaging
- GBS-Zika virus treatment and prognosis
- Others neurological complications
- General implications
- Policy and procedures
- Mini-dictionary of terms
- Key facts of NeuroZika
- Summary points
- Chapter 14: Postmortem studies: Contribution to understand the pathogenesis of congenital Zika syndrome
- Abstract
- Acknowledgments
- Introduction
- Pathogenesis of the lesions in CZS
- Conclusions
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 15: Developmental trajectories in infants and toddlers born with congenital Zika syndrome
- Abstract
- Introduction
- Zika virus and the developing brain
- Congenital Zika syndrome
- Motor development
- Cognitive development
- Communication skills
- General implications
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 16: Host genetic susceptibility to ZIKV congenital syndrome: A tale of twins
- Abstract
- Introduction
- Zika virus in Brazil
- Congenital Zika syndrome: Reasons for studying ZIKV effects in humans
- Risks for ZIKV-associated microcephaly and other CZS symptoms
- Twins: A powerful tool for investigating risks for ZIKV-associated microcephaly and CZS
- Twins’ cells are differentially infected by ZIKV
- Investigating the molecular NPCs twins’ differences
- Conclusion and follow-up
- Policies and procedures
- Mini-dictionary of terms
- Key facts of host genetic susceptibility to CZS
- Summary points
- Chapter 17: Zika virus infection disrupts development of both neurons and glial cells
- Abstract
- Introduction
- Zika virus infection disrupts normal neurogenesis
- Abnormal glial cell development after Zika virus infection
- An overall view
- Policy and procedures: Direct or maternal infection
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 18: Neurological manifestations similar to multiple sclerosis in adults after Zika virus infection
- Abstract
- Introduction
- Multiple sclerosis
- Molecular mimicry
- ZIKV induces MS-like neurological manifestation in adults
- Similar pathways
- MicroRNAs
- Concluding remarks
- Policy and procedures
- Mini-dictionary of terms
- Key facts of Zika virus and multiple sclerosis
- Summary points
- Chapter 19: Zika virus and the blood-brain barrier
- Abstract
- Acknowledgment
- Introduction
- The disruption of the blood-brain barrier by Zika virus
- Endothelial cell dysfunction during Zika virus infection
- Key facts
- Summary points
- Chapter 20: Systems immunology of flavivirus infection
- Abstract
- Introduction
- Dengue infection
- Zika infection
- Yellow fever infection
- West Nile virus infection
- Conclusions
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 21: Genetic susceptibility to congenital Zika syndrome: Current research and future perspectives
- Abstract
- Introduction
- Evidence from observational studies
- Genes already associated with CZS
- Candidate genes from Flaviviridae infections
- Conclusions and future perspectives
- Policy and procedures
- Mini-dictionary of terms
- Key facts of congenital Zika syndrome (CZS)
- Summary points
- Chapter 22: Hearing and Zika virus infection
- Abstract
- Introduction
- Auditory impairment in congenital Zika virus infection
- Auditory impairment in acquired Zika virus infection
- Pathogenesis
- Auditory screening and accompaniment
- For the future
- Policy and procedures: Hearing screening (Joint Committee on Infant Hearing, 2019)
- Policy and procedures: Major hearing assessment tests and their uses
- Mini-dictionary of terms
- Key facts of hearing loss
- Summary points
- Chapter 23: Neuromyelitis optica spectrum disorder: What it is and how it relates to Zika virus
- Abstract
- Introduction
- Epidemiology
- Pathogenesis
- Clinical features of neuromyelitis optica spectrum disorder
- Clinical core symptoms of NMOSD and its relationship to ZIKV
- Treatment
- Policy and procedures
- Mini-dictionary of terms
- Key facts of NMOSD and ZIKV
- Summary points
- Chapter 24: Zika virus infection and cytokines
- Abstract
- Introduction
- Cytokine profiling in acute ZIKV infection
- Cytokines associated with symptoms of ZIKV infection
- ZIKV infection and interferon production
- Role of T cells in ZIKV infection
- Cytokines involved in neurological complications
- Cytokines involved in nonneurological complications
- Immunoprofiles associated with fetal abnormalities in ZIKV-positive pregnancies
- Concluding remarks
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 25: Urological sequels in the scope of the Congenital Zika Syndrome
- Abstract
- Acknowledgments
- Introduction
- Neurogenic bladder
- Diagnose of neurogenic bladder
- Urodynamic studies in children with special needs
- Neurogenic bladder as a urological sequel of congenital Zika syndrome
- Treatment of neurogenic bladder in congenital Zika syndrome
- Further studies related to Zika virus in the urological system
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 26: Zika virus and impact on male fertility
- Abstract
- Introduction
- Human cases of ZIKV sexual transmission
- Prolonged shedding of ZIKV in semen
- Replication of ZIKV in vitro
- Testis damage induced by ZIKV in animal models
- Sexual transmission of ZIKV and reduced male fertility in animal models
- Effects of ZIKV on sperm cells
- Experimental drugs against ZIKV infection of the MRT
- Experimental vaccines against ZIKV infection of the MRT
- Conclusions
- Policy and procedures
- Mini-dictionary of terms
- Key facts of the impact of Zika virus on male fertility
- Summary points
- Chapter 27: Testicular cell types and infection by Zika virus
- Abstract
- Acknowledgment
- Introduction
- Structural and functional anatomy of the testis
- Zika virus infection of testicular cells
- Testicular pathology associated with ZIKV infection
- Persistent ZIKV infection of testicular cells
- Testicular cell pathways affected by ZIKV infection
- Policy and procedures: Diagnosis of testicular infection by ZIKV, sexual transmission, and prevention
- Mini-dictionary of terms
- Key facts of testicular cell types and infection by ZIKV
- Summary points
- Chapter 28: Proteome alterations promoted by Zika virus infection
- Abstract
- Introduction
- Strains and infection conditions
- Brazilian strains of ZIKV
- Proteomic techniques
- Main molecular alterations after ZIKV infection
- Signaling pathways are affected by ZIKV infection
- The immune cell response for viral infection
- Neurological-associated molecular alterations caused by ZIKV
- Alteration of metabolic processes as a consequence of ZIKV infection
- Concluding remarks
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Chapter 29: SOMAscan proteomics of Zika-infected cells
- Abstract
- Introduction
- Proteomics
- SOMAscans as an alternate proteomic strategy
- SOMAscan-determined protein dysregulations in cancer and neurological diseases
- SOMAscan-determined ZIKV-induced protein dysregulation
- ZIKV infection induces similar and dissimilar protein dysregulation in different cells
- Different biological functions are activated and inhibited by ZIKV in a cell-dependent manner
- Future perspectives
- Policy and procedures: Measuring host protein alterations
- Mini-dictionary of terms
- Key facts of Zika virus-induced proteomic responses
- Summary points
- Chapter 30: Zika virus as an oncolytic therapy against brain tumors
- Abstract
- Introduction
- ZIKV and brain tumors
- Safety, virus delivery, and conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Section C: International aspects
- Chapter 31: Zika virus in Brazil
- Abstract
- Historical perspective
- Introduction of ZIKV to Brazil
- ZIKV phylogenetics
- ZIKA vectors in Brazil
- ZIKA epidemiology update
- Conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts of Brazil
- Summary points
- Chapter 32: Zika virus and the Middle East
- Abstract
- Introduction
- ZIKV vectors in the Middle East
- Travel-related ZIKV in the Middle East
- What can we learn from the absence of Zika in the Middle East?
- Conclusions
- Policy and procedures
- Mini-dictionary of terms
- Key facts on Zika virus in travelers from the Middle East
- Summary points
- Chapter 33: Genetic diversity of Zika virus in Thailand: How does this compare with other countries
- Abstract
- Introduction
- Timeline of the ZIKV outbreaks in Thailand
- Vectors of ZIKV
- ZIKV genetic variability in Thailand
- Policy and procedures
- Mini-dictionary of terms
- Key facts of Zika virus (ZIKV)
- Summary points
- Chapter 34: Zika virus in Vietnam: Biology, transmission, pathology, associated conditions, and controls
- Abstract
- Introduction
- Biology of ZIKV in Vietnam
- Transmission of ZIKV in Vietnam
- Pathology of ZIKV infection in Vietnam
- Associated conditions of ZIKV infection in Vietnam
- Controls of ZIKV in Vietnam
- Policy and procedures
- Key facts
- Summary points
- Chapter 35: Zika virus in Vietnam: Epidemic, distribution, strain origin, and potential risks for community health
- Abstract
- Introduction
- Epidemics of ZIKV in Vietnam
- Distribution of ZIKV in Vietnam
- Strain origin of ZIKV in Vietnam
- Potential risks of ZIKV in Vietnam
- Policy and procedures: Mosquito vector control
- Key facts from the World Health Organization
- Summary points
- Chapter 36: Zika virus infection in Mexico: Epidemiological and clinical data
- Abstract
- Introduction
- Background
- Zika distribution and extent in Mexico
- Microcephaly and congenital syndrome associated with Zika
- Guillain-Barré syndrome associated with Zika in Mexico
- Policy and procedures
- Mini-dictionary of terms
- Key facts
- Summary points
- Section D: Features of the virus and transmission
- Chapter 37: Cytopathicity and pathogenesis of Zika virus strains
- Abstract
- Introduction
- ZIKV genome and evolution
- Cytopathic effects and replication capacity of ZIKV lineages
- The innate immune cell response triggered by different ZIKV lineages contributes to their cytopathicity
- Cellular RNA interference and stress response contribute to cytopathicity
- Contemporary Asian-American ZIKV strains contain key mutations that contribute to the pathogenesis
- Conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts of cytopathicity and pathogenesis
- Summary points of cytopathicity and pathogenesis
- Chapter 38: Molecular evolution and codon usage bias of Zika virus
- Abstract
- Introduction
- What is codon usage bias?
- Evolutionary theories of codon usage bias
- Genetic variability and molecular evolution of ZIKV
- Evolution of the codon usage bias in ZIKV
- Vaccines development as application of the study of codon usage bias in viruses
- Conclusions and future directions
- Policy and procedures: Quantification of codon usage bias
- Mini-dictionary of terms
- Key facts of codon usage in ZIKV
- Summary points
- Chapter 39: Endosomal compartmentation and the transport route of Zika virus
- Abstract
- Introduction
- The Zika virus
- Apoptotic mimicry of ZIKV
- Interaction between the Zika virus and the cell
- Clathrin-dependent endocytosis of Zika virus
- Intracellular trafficking of the ZIKV
- Early stages of virus infection and antiviral drug development
- Final remarks
- Mini-dictionary of terms
- Key facts of intracellular transport compartments
- Key facts of ZIKV structure
- Summary points
- Chapter 40: Location of virus antigens in murine tissues infected with Zika virus
- Abstract
- Introduction
- Mouse models of ZIKV infection
- Spread of ZIKV through the infected mice
- The congenital Zika syndrome
- Other nervous structures
- Infection of the placenta
- Infection of the reproductive system
- Policy and procedures: Immunofluorescence stain for frozen tissue sections
- Mini-dictionary of terms
- Key facts of ZIKV distribution in mice
- Summary points
- Chapter 41: The role of seminal Zika viral shedding: Tropism, duration, and magnitude
- Abstract
- Introduction
- Zika virus tropism for the male reproductive tract
- Duration and magnitude of ZIKV shedding in semen
- Concluding remarks
- Policy and procedures
- Mini-dictionary of terms
- Key facts of Zika virus sexual transmission
- Summary points
- Chapter 42: Nonhuman occurrence of Zika virus infection: Implications for control
- Abstract
- Introduction
- Role of vertebrate animals in ZIKV epidemiology
- Identification of ZIKV new reservoir hosts
- Laboratory diagnosis
- The contribution of animal models to the study of Zika virus infections
- Conclusion
- Policy and procedures
- Mini-dictionary of terms
- Key facts on the role of animals in ZIKV transmission
- Summary points
- Chapter 43: Zika virus intrusion into the blood supply: Concerns about transfusion safety
- Abstract
- Introduction
- Viral dissemination: Identification of ZIKV in asymptomatic blood donors
- Potential risks of transfusion transmission and vulnerable populations
- Transfusion transmission mitigation strategies
- Conclusions and pending research areas
- Policy and procedures
- Mini-dictionary of terms
- Key facts of pathogen inactivation techniques
- Summary points
- Section E: Resources
- Chapter 44: Research and recommended resources on Zika virus, pathology, and control
- Abstract
- Acknowledgments
- Introduction
- Bibliometric statistics
- Resources
- Policy and procedure
- Mini-dictionary of terms
- Key facts
- Summary points
- Index
- Edition: 1
- Published: June 25, 2021
- Imprint: Academic Press
- No. of pages: 576
- Language: English
- Hardback ISBN: 9780128202685
- eBook ISBN: 9780323903080
CM
Colin R. Martin
CH
Caroline Hollins-Martin
VP
Victor R Preedy
RR
Rajkumar Rajendram
Dr Rajkumar Rajendram is a clinician scientist with a focus on internal medicine, anaesthesia, intensive care and peri-operative medicine. He graduated with distinctions from Guy’s, King’s and St. Thomas Medical School, King’s College London in 2001. As an undergraduate he was awarded several prizes, merits and distinctions in pre-clinical and clinical subjects.
Dr Rajendram began his post-graduate medical training in general medicine and intensive care in Oxford. He attained membership of the Royal College of Physicians (MRCP) in 2004 and completed specialist training in acute and general medicine in Oxford in 2010. Dr Rajendram subsequently practiced as a Consultant in Acute General Medicine at the John Radcliffe Hospital, Oxford.
Dr Rajendram also trained in anaesthesia and intensive care in London and was awarded a fellowship of the Royal College of Anaesthetists (FRCA) in 2009. He completed advanced training in regional anaesthesia and intensive care. He was awarded a fellowship of the Faculty of Intensive Care Medicine (FFICM) in 2013 and obtained the European diploma of intensive care medicine (EDIC) in 2014. He then moved to the Royal Free London Hospitals as a Consultant in Intensive Care, Anaesthesia and Peri-operative Medicine. He has been a fellow of the Royal College of Physicians of Edinburgh (FRCP Edin) and the Royal College of Physicians of London (FRCP Lond) since 2017 and 2019 respectively. He is currently a Consultant in Internal Medicine at King Abdulaziz Medical City, National Guard Heath Affairs, Riyadh, Saudi Arabia.
Dr Rajendram’s focus on improving outcomes from Coronavirus Disease 2019 (COVID-19) has involved research on point of care ultrasound and phenotypes of COVID-19. Dr Rajendram also recognises that nutritional support is a fundamental aspect of medical care. This is particularly important for patients with COVID-19. As a clinician scientist he has therefore devoted significant time and effort into nutritional science research and education. He is an affiliated member of the Nutritional Sciences Research Division of King’s College London and has published over 400 textbook chapters, review articles, peer-reviewed papers and abstracts.